Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Iron depletion enhances the effect of sorafenib in hepatocarcinoma.
Urano S, Ohara T, Noma K, Katsube R, Ninomiya T, Tomono Y, Tazawa H, Kagawa S, Shirakawa Y, Kimura F, Nouso K, Matsukawa A, Yamamoto K, Fujiwara T. Urano S, et al. Among authors: tomono y. Cancer Biol Ther. 2016 Jun 2;17(6):648-56. doi: 10.1080/15384047.2016.1177677. Epub 2016 Apr 18. Cancer Biol Ther. 2016. PMID: 27089255 Free PMC article.
Iron depletion is a novel therapeutic strategy to target cancer stem cells.
Ninomiya T, Ohara T, Noma K, Katsura Y, Katsube R, Kashima H, Kato T, Tomono Y, Tazawa H, Kagawa S, Shirakawa Y, Kimura F, Chen L, Kasai T, Seno M, Matsukawa A, Fujiwara T. Ninomiya T, et al. Among authors: tomono y. Oncotarget. 2017 Oct 12;8(58):98405-98416. doi: 10.18632/oncotarget.21846. eCollection 2017 Nov 17. Oncotarget. 2017. PMID: 29228699 Free PMC article.
A novel synergistic effect of iron depletion on antiangiogenic cancer therapy.
Ohara T, Noma K, Urano S, Watanabe S, Nishitani S, Tomono Y, Kimura F, Kagawa S, Shirakawa Y, Fujiwara T. Ohara T, et al. Among authors: tomono y. Int J Cancer. 2013 Jun 1;132(11):2705-13. doi: 10.1002/ijc.27943. Epub 2012 Dec 4. Int J Cancer. 2013. PMID: 23161652 Free article.
A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness.
Katsura Y, Ohara T, Noma K, Ninomiya T, Kashima H, Kato T, Sato H, Komoto S, Narusaka T, Tomono Y, Xing B, Chen Y, Tazawa H, Kagawa S, Shirakawa Y, Kasai T, Seno M, Matsukawa A, Fujiwara T. Katsura Y, et al. Among authors: tomono y. Cancers (Basel). 2019 Feb 3;11(2):177. doi: 10.3390/cancers11020177. Cancers (Basel). 2019. PMID: 30717462 Free PMC article.
Autophagy: Can it become a potential therapeutic target?
Bao XH, Naomoto Y, Hao HF, Watanabe N, Sakurama K, Noma K, Motoki T, Tomono Y, Fukazawa T, Shirakawa Y, Yamatsuji T, Matsuoka J, Takaoka M. Bao XH, et al. Among authors: tomono y. Int J Mol Med. 2010 Apr;25(4):493-503. doi: 10.3892/ijmm_00000369. Int J Mol Med. 2010. PMID: 20198296 Review.
Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing mice.
Nishikawa T, Takaoka M, Ohara T, Tomono Y, Hao H, Bao X, Fukazawa T, Wang Z, Sakurama K, Fujiwara Y, Motoki T, Shirakawa Y, Yamatsuji T, Tanaka N, Fujiwara T, Naomoto Y. Nishikawa T, et al. Among authors: tomono y. Cancer Biol Ther. 2013 Mar;14(3):230-6. doi: 10.4161/cbt.23294. Epub 2013 Jan 4. Cancer Biol Ther. 2013. PMID: 23291985 Free PMC article.
170 results